Dr. Daniel Kyu Jeong, MD

Dr. Jeong practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Jeong's NPI, 1871759654, was assigned on July 31, 2008. Dr. Jeong graduated from Carver College of Medicine in 2008. Dr. Jeong holds Florida license ME119935.

Dr. Jeong's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Jeong also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Jeong's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is MBB Radiology. Dmand AI also links Dr. Jeong to 2 more group practices and clinics, 1 breast imaging center, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jeong practices, 5 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Jeong's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Jeong is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Jeong's licenses on file in 3 states: Florida, Illinois and Wisconsin.

CMS data shows 1,384 Medicare services from Dr. Jeong across 22 procedure codes in 2024, for 950 Medicare patients. Medicare paid $63,947 for them.

CMS counts 950 Medicare patients who saw Dr. Jeong in 2024. The largest group is 65 to 74, with 477 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jeong's median patient age at 68, with 50% women.

In 2017, Dr. Jeong wrote 31 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $693 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Jeong for performance year 2024, reported as part of a group. Dr. Jeong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Jeong, published from 2014 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Magnetic Resonance Imaging, Tomography, X-Ray Computed and Pancreatic Neoplasms. Dr. Jeong has published most often in Cancers (Basel). Dr. Jeong's most frequent co-authors are Kenneth Leslie Gage, MD, PhD, Jason Bates Fleming, MD and Pamela J. Hodul, MD.

Dmand AI links Dr. Jeong to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pancreatic Cyst and Cysts.

CMS Open Payments shows 58 general payments to Dr. Jeong from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 82% of the total. Siemens Medical Solutions USA, Inc. paid the most, $11,501.

Dr. Jeong graduated from Carver College of Medicine in 2008. Dr. Jeong is a member of SIR.

Dr. Jeong is in network with 6 carriers, including Excellus BlueCross BlueShield, United Healthcare and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.